GlassScriptPhysician profile
Jodi Fox-Mellul
NPI 1053616631
$14,975.36
in general payments reported to CMS, 2019-2025
51 companies · $1,893 in 2025
The $1,893 reported for 2025 was more than what 76% of Endocrinology, Diabetes & Metabolism providers received nationally (typical 2025 total: $506).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $2,546 · 2020: $1,818 · 2021: $2,281 · 2022: $2,134 · 2023: $1,979 · 2024: $2,323 · 2025: $1,893.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $6,196.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $6,195.97 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novo Nordisk INC | $2,196.63 | 2019-2025 | Rybelsus, Ozempic, Wegovy |
| Mannkind Corporation | $1,993.52 | 2019-2025 | Afrezza |
| Amneal Pharmaceuticals LLC | $1,020.00 | 2019-2025 | Unithroid |
| Sanofi-Aventis U.S. LLC | $931.81 | 2019-2025 | |
| Abbott Laboratories | $884.94 | 2019-2025 | Freestyle Libre 3 |
| Amgen INC. | $879.20 | 2019-2025 | Evenity, Tepezza, Repatha |
| Lilly USA, LLC | $757.52 | 2019-2025 | Mounjaro, Jardiance, Zepbound |
| Corcept Therapeutics | $744.38 | 2019-2025 | Korlym |
| Cequr Corporation | $575.75 | 2021-2025 | Cequr Simplicity |
| Boehringer Ingelheim Pharmaceuticals, INC. | $566.99 | 2019-2025 | Jardiance, Synjardy, Tradjenta |
| Insulet Corporation | $458.54 | 2019-2025 | Omnipod |
| Xeris Pharmaceuticals, INC. | $440.06 | 2020-2025 | Recorlev, Gvoke Hypopen |
| Bayer Healthcare Pharmaceuticals INC. | $432.88 | 2021-2025 | |
| Merck Sharp & Dohme LLC | $286.95 | 2019-2022 | |
| Abbvie INC. | $261.57 | 2019-2025 |
Show all 51 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Antares Pharma, INC. | $231.12 | 2024-2025 | Xyosted |
| Tolmar, INC. | $217.61 | 2023-2025 | Jatenzo |
| Amarin Pharma, INC. | $214.88 | 2019-2022 | |
| Dexcom, INC. | $213.69 | 2019-2025 | Dexcom G6 Transmitter |
| Astrazeneca Pharmaceuticals LP | $183.78 | 2019-2023 | Farxiga |
| Recordati_rare_diseases_inc. | $142.27 | 2024-2025 | Isturisa, Signifor Lar |
| Janssen Pharmaceuticals, INC | $114.83 | 2019-2020 | |
| Alexion Pharmaceuticals, INC. | $108.63 | 2019-2024 | Strensiq |
| Zealand Pharma US, INC. | $92.87 | 2021 | |
| Ascendis Pharma Endocrinology INC | $88.66 | 2025 | Yorvipath |
| Tandem Diabetes Care, INC. | $84.19 | 2019-2022 | |
| Ibsa Pharma INC. | $82.56 | 2019-2025 | Tirosint, Licart, Flector |
| Kowa Pharmaceuticals America, INC. | $82.12 | 2019-2022 | |
| Medtronic, INC. | $74.44 | 2022-2025 | Minimed 780g, Minimed 770g, Inpen Smart Insulin Delivery System |
| Radius Health, INC. | $67.53 | 2021-2024 | |
| Madrigal Pharmaceuticals | $46.02 | 2025 | Rezdiffra |
| Beta Bionics, INC. | $42.61 | 2023-2025 | Ilet Bionic Pancreas, Ilet Insulin Infusion Kit Inset, Ilet Insulin Infusion Kit Contact Detach |
| Halozyme INC | $41.81 | 2023 | |
| Intuity Medical INC | $41.16 | 2022-2023 | Pogo Automatic Blood Glucose Monitoring System |
| Clarus Therapeutics INC. | $40.03 | 2021 | |
| Currax Pharmaceuticals LLC | $38.77 | 2020-2023 | Contrave |
| Shire North American Group INC | $37.18 | 2019 | |
| Pfizer INC. | $32.16 | 2023 | |
| Acella Pharmaceuticals, LLC | $29.72 | 2024 | NP Thyroid 60 |
| Novartis Pharmaceuticals Corporation | $28.71 | 2024 | |
| Eisai INC. | $26.67 | 2019 | |
| Sequel Med Tech, LLC | $17.67 | 2025 | Twiist |
| Chiesi USA, INC. | $17.06 | 2024 | Mycapssa |
| Rgh Enterprises LLC | $15.46 | 2025 | |
| Rhythm Pharmaceuticals, INC. | $14.67 | 2021 | |
| Medtronic Minimed, INC. | $13.34 | 2019 | |
| Ultragenyx Pharmaceutical INC. | $13.16 | 2020 | |
| Azurity Pharmaceuticals, INC. | $12.90 | 2023 | Adthyza |
| Horizon Therapeutics Plc | $12.71 | 2023 | Tepezza |
| Amryt Pharma Holdings LTD | $11.83 | 2022 | |
| Sanofi Pasteur INC. | $11.80 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jodi Fox-Mellul listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.